Reviewer Board
Members of the reviewer board are selected from all Current Oncology reviewers for regularly providing timely high quality reports on submitted manuscripts. Responsibilities of reviewers are available here.
Members
2. UBC School of Nursing, T201 2211 Wesbrook Mall, Vancouver, BC V6T2B5, Canada
Interests: oncology; nursing; geriatric oncology; qualitative methods; mixed methods; self-management; supportive care
Interests: musculoskeletal oncology
Interests: nuclear medicine; occupational medicine; hybrid PSMA imaging; preventive medicine; prostate specific membrane antigen (PSMA) PET/CT; acquired von Willebrand syndrome; bleeding risk; hyperfibrinolytic status; PSMA-PET/C; PSMA-PET/MRI
Interests: neuroendocrine neoplasms; biomarkers; imaging; pathology; cancer diagnostics
Interests: survivor; cancer survivorship; survivorship; insurance disparity; transportation barrier; cancer pain
Interests: epithelial-mesenchymal transition; chemical warfare agent-induced toxicity; cancer biology
Interests: gastric; hepato-biliary-pancreatic cancer; gastrointestinal cancer; ERCP; EUS; interventional endoscopy; palliative medicine; cancer screening
Interests: genetics in cancer; epigenetic regulation (methylation, microRNA); endocrine cancer; cancer progression; cancer therapeutics
Interests: cancer; surgery
Interests: chronic hepatitis B; chronic hepatitis C; innate immune response; adaptive imune response; cytokine; chemokine
Interests: clinical pathology; hematopoietic stem cells; cell biology; leukemias; oncology
Interests: reactive oxygen species; signaling pathways; Neosetophomone B; drug resistance; sanguinarine
Interests: body fluids; platelets; clinical chemistry; serology; hematology
Interests: lung cancer; targeted therapies; Immunology; immunotherapy; biomarker
2. Laboratory of Cytometry, Nencki Institute of Experimental Biology, Polish Academy of Sciences, 02-093 Warsaw, Poland
Interests: leukemia; DNA repair; DNA damage response; PARP inhibitor; POLQ inhibitor; bone marrow microenvironment; cell signaling; DNA methylation
Interests: DNA damage and response; cancer target therapy
Interests: population genetics; cancer therapy; cancer evolution; single cell sequencing; computational biology
Interests: population genetics; cancer genomics; machine learning; computational mathematics
2. Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), 4200-072 Porto, Portugal
3. Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto (ICBAS-UP), 4200-072 Porto, Portugal
Interests: biomarkers; bladder cancer; epigenetics; histones; kidney cancer; methylation; microRNAs; pathology; prostate cancer; testicular germ cell tumors; uropathology
Interests: breast cancer; systemic therapies; real-world outcomes; risk assessment; prevention
Interests: melanoma; non-melanoma skin cancer; dermatologic surgery; Mohs micrographic surgery
Interests: cancer biology; AI in precision oncology; cancer therapy drugs
Interests: clinical medicine; cancer research; biomedical sciences
Interests: diagnostic radiology; interventional radiology; brain tumors; pediatric radiology; neurooncology; neuroradiology; oncology
Interests: breast cancer; biomarker; proteomics; mass spectrometry; proteasome biology
Interests: myeloma; cancer immunology
Interests: soft-tissue sarcomas; immunotherapy; neoadjuvant treatment; the mTOR pathway; leiomyosarcomas; undifferentiated pleomorphic sarcomas
2. Cork University Hospital, Cork, Ireland
Interests: clinical trials; breast cancer; climate change; cybersecurity; survivorship
Interests: cancer disparities; lung cancer; screening for cancer; cancer surveillance; implementation research; LDCT screening
Interests: medical physics; radiotherapy; stereotactic radiosurgery (SRS/SBRT); gold nanoparticle radiosensitization; patient-specific quality assurance




